Retour
Prix HUTCHMED (China) Limited (HMDCF)
Graphique du cours de l'action HMDCF
HMDCF Gagner
HUTCHMED (China) Limited
$3.02
0%
$0
À la fermeture : Feb 06, 16:00:00 GMT-5
$3.02
0%
$0
Post-Marché: Feb 06, 20:00:00 GMT-5
Derniers résultats des bénéfices : Q2 '23
Signalé : 2023-07-31
Bénéfices historiques
Trimestriellement
Annuel
EPS
Revenus
Earnings FAQ
Comment le bénéfice par action récent de HMDCF se compare-t-il aux attentes ?
Comment les revenus de HUTCHMED (China) Limited HMDCF se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour HUTCHMED (China) Limited ?
Quel est le score de qualité des bénéfices pour HUTCHMED (China) Limited ?
Quand HUTCHMED (China) Limited publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de HUTCHMED (China) Limited ?
HUTCHMED (China) Limited a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$3.02
Prix d'ouverture
$3.81
Plage de la journée
$3.02 - $3.81
Plage de 52 semaines
$3.02 - $3.81
Volume
468
Volume moyen
180
BPA (TTM)
0.53
Rendement en dividend
--
Capitalisation boursière
$2.5B
Qu’est-ce que HUTCHMED (CHINA) LIMITED ?
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,780 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved